PhD research fellow in liver immunology (ref 251444)

Primary sclerosing cholangitis (PSC) is a chronic liver disease for which no current therapy exists and which therefore is the most important indication for liver transplantation in Norway. NoPSC is a world-leading research center for the chronic liver disease primary sclerosing cholangitis (PSC). The center counts 35-40 employees from all over the world, covering all aspects of PSC-related research, from basic genomic and experimental studies to clinical research and clinical trials. (https://www.med.uio.no/klinmed/english/research/groups/primary-sclerosing-cholangitis/index.html).

In our previous studies, we have identified a disease causing mutation for PSC and observed that mice with a similar mutation are more vulnerable to persistent biliary inflammation. This observation cannot be fully explained by known mechanisms related to immune resistance or regulation. Therefore, we now seek a highly motivated and creative co-worker to further explore the molecules involved in disease tolerance and tissue adaptation.

For more information and how to apply: PhD research fellow in liver immunology (251444) | University of Oslo (jobbnorge.no)